SHP639 (n=60)
SHP639-101
Phase 1 small_molecule completed
Quick answer
SHP639 (n=60) for Primary Open-angle Glaucoma (POAG) is a Phase 1 program (small_molecule) at TAKEDA PHARMACEUTICAL CO LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- TAKEDA PHARMACEUTICAL CO LTD
- Indication
- Primary Open-angle Glaucoma (POAG)
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed